Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

15.64

+1.00 (6.83%)

At close: Jun 8, 2026, 4:00 PM EDT

15.40

-0.24 (-1.53%)

After-hours: Jun 8, 2026, 5:02 PM EDT

Nurix Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Equivalents	71.2	246.96	110	54.63	64.47	80.51
Short-Term Investments	469.54	345.98	499.59	233.28	244.67	215.21
Cash & Short-Term Investments	540.73	592.94	609.58	287.91	309.14	295.72
Cash Growth	11.31%	-2.73%	111.73%	-6.87%	4.54%	5.18%
Accounts Receivable	-	-	-	-	-	6
Other Receivables	-	-	-	-	-	0.2
Total Trade Receivables	-	-	-	-	-	6.2
Other Current Assets	13.66	13.88	9.8	7.6	9.31	9.19
Total Current Assets	554.39	606.82	619.39	295.5	318.45	311.12
Net Property, Plant & Equipment	73.35	73.01	45.9	47.95	29.51	25.35
Long-Term Investments	-	-	-	7.42	63.88	137.19
Other Long-Term Assets	8.38	8.31	4.06	4.72	4.92	3.12
Total Assets	636.13	688.14	669.34	355.6	416.76	476.77
Accounts Payable	10.29	11.22	11.48	6.4	5.06	6.65
Accrued Expenses	59.95	54.85	37.99	24.97	22.43	14.55
Current Portion of Leases	3.2	2.82	8.01	7.49	5.53	3.85
Unearned Revenue	18.75	17.58	38.36	48.1	37.63	41.21
Total Current Liabilities	92.2	86.47	95.85	86.96	70.66	66.26
Long-Term Leases	55.45	52.91	20.29	23.13	6.43	9.19
Other Long-Term Liabilities	7.59	10.01	26.21	45.02	35.97	59.02
Total Long-Term Liabilities	63.04	62.92	46.5	68.15	42.41	68.21
Total Liabilities	155.24	149.39	142.35	155.11	113.06	134.47
Common Stock	0.1	0.1	0.08	0.05	0.05	0.05
Additional Paid-in Capital	1,571	1,542	1,266	746.3	709.22	563.76
Accumulated Other Comprehensive Income	0.06	0.11	0.15	-0.66	-4.32	-0.61
Retained Earnings	-1,090	-1,003	-738.77	-545.2	-401.25	-220.89
Shareholders' Equity	480.89	538.75	526.99	200.49	303.7	342.3
Total Liabilities & Equity	636.13	688.14	669.34	355.6	416.76	476.77
Total Debt	58.66	55.73	28.3	30.61	11.96	13.04
Net Cash (Debt)	482.08	537.21	581.28	257.29	297.18	282.68
Net Cash Growth	-10.26%	-7.58%	125.92%	-13.42%	5.13%	0.55%
Net Cash Per Share	5.17	6.20	8.66	4.74	6.11	6.59
Book Value	480.89	538.75	526.99	200.49	303.7	342.3
Book Value Per Share	5.15	6.22	7.85	3.69	6.25	7.98
Tangible Book Value	480.89	538.75	526.99	200.49	303.7	342.3
Tangible Book Value Per Share	5.15	6.22	7.85	3.69	6.25	7.98

SEC Filings: 10-K · 10-Q